Abstract

Radiation-induced pulmonary fibrosis (RIPF) is a debilitating side effect of radiation therapy (RT) of several cancers including lung and breast cancers. Current clinical methods to assess and monitor RIPF involve diagnostic computed tomography (CT) imaging, which is restricted to anatomical macroscopic changes. Confocal laser endomicroscopy (CLE) or fluorescence endomicroscopy (FE) in combination with a fibrosis-targeted fluorescent probe allows to visualize RIPF in real-time at the microscopic level. However, a major limitation of FE imaging is the lack of anatomical localization of the endomicroscope within the lung. In this work, we proposed and validated the use of x-ray fluoroscopy-guidance in a rat model of RIPF to pinpoint the location of the endomicroscope during FE imaging and map it back to its anatomical location in the corresponding CT image. For varying endomicroscope positions, we observed a positive correlation between CT and FE imaging as indicated by the significant association between increased lung density on CT and the presence of fluorescent fiber structures with FE in RT cases compared to Control. Combining multimodality imaging allows visualization and quantification of molecular processes at specific locations within the injured lung. The proposed image-guided FE method can be extended to other disease models and is amenable to clinical translation for assessing and monitoring fibrotic damage.

Highlights

  • Radiation-induced pulmonary fibrosis (RIPF) is a debilitating side effect of radiation therapy (RT) of several cancers including lung and breast cancers

  • RIPF is closely related to idiopathic pulmonary fibrosis and the methodology presented here could be extended to this disease and similar fibrotic diseases as well

  • We present and evaluate macroscopic fluoroscopy-guidance to localize the tip of the endomicroscope during fluorescence endomicroscopy (FE) imaging in a rat model of RIPF

Read more

Summary

Introduction

Radiation-induced pulmonary fibrosis (RIPF) is a debilitating side effect of radiation therapy (RT) of several cancers including lung and breast cancers. Current clinical methods to assess and monitor RIPF involve diagnostic computed tomography (CT) imaging, which is restricted to anatomical macroscopic changes. To assess the extent of RIPF clinically, a chest x-ray (2-dimensional) or its 3D equivalent computed tomography (CT) scan is performed[5] Both methods detect differences in tissue density as a basis of image contrast. FE is already used clinically with autofluorescence or in combination with fluorescent probes for bronchoscopy to study the progression of different lung diseases[14]. It has not been applied in clinical RIPF assessment yet. We present a fluorescent collagen probe in combination with FE imaging to enable visualization of RIPF at the cellular level in vivo in a rat model

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call